THYROCARE TECHNOLOGIES
Back to Balance Sheet
|
THYROCARE TECHNOLOGIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.62 Cr | ₹0.85 Cr | ₹1.61 Cr | ₹51 Cr | ₹54 Cr |
What is the latest Contingent Liabilities ratio of THYROCARE TECHNOLOGIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.62 Cr |
Mar2023 | ₹0.85 Cr |
Mar2022 | ₹1.61 Cr |
Mar2021 | ₹51 Cr |
Mar2020 | ₹54 Cr |
How is Contingent Liabilities of THYROCARE TECHNOLOGIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.62 Cr | -27.06 | |
Mar2023 | ₹0.85 Cr | -47.20 | |
Mar2022 | ₹1.61 Cr | -96.83 | |
Mar2021 | ₹51 Cr | -6.44 | |
Mar2020 | ₹54 Cr | - |
Compare Contingent Liabilities of peers of THYROCARE TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
THYROCARE TECHNOLOGIES | ₹3,831.6 Cr | 0.9% | 5% | 21.7% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹106,401.0 Cr | -2.5% | 11.8% | 32.1% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹96,746.2 Cr | 3.2% | 11.2% | 4.4% | Stock Analytics | |
FORTIS HEALTHCARE | ₹50,053.7 Cr | 2.7% | 8.7% | 63.9% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹34,469.5 Cr | 3.5% | 16.8% | 31% | Stock Analytics | |
GLOBAL HEALTH | ₹33,488.8 Cr | 2.1% | 8.4% | -7% | Stock Analytics |
THYROCARE TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
THYROCARE TECHNOLOGIES | 0.9% |
5% |
21.7% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses